Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Health Related Quality of Life (HRQoL) among Breast Cancer Patients Receiving Chemotherapy in Hospital Melaka: Single Centre Experience

  • Published : 2016.12.01
⟨ Previous Next ⟩

Abstract

Objective: To investigate the impact of chemotherapy on quality of life (QoL) among breast cancer patients and to evaluate the relationship with age, cancer stage and presence of any comorbidity. Methods: A prospective study was conducted among breast cancer patients receiving chemotherapy in Hospital Melaka from 1st January 2014 to 31st July 2014. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) was given to patients to fill in prior chemotherapy (baseline) and after the third cycle of chemotherapy. Socio-demographic and clinical data were collected and analyzed using SPSS version 20. Result: Respondents were 32 female patients [mean age (SD): 49.7(9.93) years]. They reported a significant lower global health status (P < 0.01) and significant higher symptoms of nausea and vomiting (P < 0.01), loss of appetite (P = 0.028) and diarrhea (P = 0.026) after the third cycle of chemotherapy as compared to baseline. Compare to, this study showed significant better emotional functioning (P < 0.01) and social functioning (P < 0.01) than the EORTC QLQ-C30 Reference Values 2008 for breast cancer cases. Under symptom scales higher scores were noted for appetite loss (P = 0.017), nausea and vomiting (P < 0.01). Age, stage and comorbidity had no clear associations with global health status in our patients (P > 0.05). Conclusion: Chemotherapy did reduce the QoL of breast cancer patients. Management of chemotherapy-induced loss of appetite, diarrhea, nausea and vomiting should be improved for a better outcome.

Keywords

References

  1. Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The european organization for research and treatment of cancer qlq-c30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76. https://doi.org/10.1093/jnci/85.5.365
  2. Akin S, Can G, Durna Z, Aydiner A (2008). The quality of life and self-efficacy of turkish breast cancer patients undergoing chemotherapy. Eur J Oncol Nurs, 12, 449-56. https://doi.org/10.1016/j.ejon.2008.07.006
  3. Bourdeanu L, Frankel P, Yu W, et al (2012). Chemotherapyinduced nausea and vomiting in asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy. J Support Oncol, 10, 149-54. https://doi.org/10.1016/j.suponc.2011.10.007
  4. Cohen L, De Moor CA, Eisenberg P, et al (2007). Chemotherapyinduced nausea and vomiting-incidence and impact on patient quality of life at community oncology settings. Supp Care Cancer, 15, 497-503. https://doi.org/10.1007/s00520-006-0173-z
  5. Cohn SH, Vartsky D, Yasumura S, et al (1980). Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol, 239, 524-30.
  6. Dehkordi A, Heydarnejad MS, Fatehi D (2009). Quality of life in cancer patients undergoing chemotherapy. Oman Med J, 24, 204-7.
  7. Desalvo KB, Bloser N, Reynolds K, et al (2006). Mortality prediction with a single general self-rated health question: a meta-analysis. J Gen Intern Med, 21, 267-75. https://doi.org/10.1111/j.1525-1497.2005.00291.x
  8. Eisenbraun J, Scheer R, Kroz M, et al (2011). Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract. Phytomedicine, 18, 151-7. https://doi.org/10.1016/j.phymed.2010.06.013
  9. Fayers PM, Aaronson NK, Bjordal K, et al (2001). Eortc QLQ-C30 scoring manual, european organisation for research and treatment of cancer. Cancer Invest, 19, 573-80. https://doi.org/10.1081/CNV-100104284
  10. Gozzo T, Moyses A, Silva P, Almeida A (2013). Nausea, vomiting and quality of life in women with breast cancer receiving chemotherapy. Rev Gaucha Enferm, 34, 110-6. https://doi.org/10.1590/S1983-14472013000300014
  11. Helena M, Christina B, Bo N, Brandberg Y (2000). Healthrelated quality of life measured by the eortc qlq-c30: reference values from a large sample of the swedish population. Acta Oncologica, 39, 477-84. https://doi.org/10.1080/028418600750013384
  12. Holzner B, Kemmler G, Kopp M, et al (2001). Quality of life in breast cancer patients-not enough attention for long-term survivors?. Psychosomatics, 42, 117-23. https://doi.org/10.1176/appi.psy.42.2.117
  13. Kadowaki S,Yamaguchi K (2011). Chemotherapyinduced stomatitis and diarrhea. Gan to kagaku ryoho. Cancer Chemother Pharmacol, 38, 1761-6.
  14. Kallman D, Plato C, Tobin J (1990). The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol, 45, 82-8. https://doi.org/10.1093/geronj/45.3.M82
  15. Keefe D, Brealey J, Goland G, Cummins A ( 2000). Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut, 47, 632-7. https://doi.org/10.1136/gut.47.5.632
  16. Lua L, Zakaria NS, Mamat NM (2012). Health-related quality of life profile in relation to chemotherapy-induced nausea and vomiting among breast cancer patients. Asian J Psychiatr, 13.
  17. Magaji BA, Moy FM, Roslani AC, et al (2012). Health-related quality of life among colorectal cancer patients in malaysia: a study protocol. BMC Cancer, 12, 384. https://doi.org/10.1186/1471-2407-12-384
  18. MOH, Malaysia (2011). Chemotherapy protocols systemic therapy of cancer. Department of Radiotherapy and Oncology/ Hospital Kuala Lumpur, Ministry of Health Malaysia. .
  19. Melicher B & Zezulova M 2011. The significance of altered gastrointestinal permeability in cancer patients. Curr opin support palliat care, 5, 47-54. https://doi.org/10.1097/SPC.0b013e328343a043
  20. Mols F, Vingerhoets AJ, Coebergh JW, Van De Poll-Franse LV (2005). Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer, 41, 2613-9. https://doi.org/10.1016/j.ejca.2005.05.017
  21. Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer, 8, 330. https://doi.org/10.1186/1471-2407-8-330
  22. Ogce F, Ozkan S (2008). Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer. Asian Pac J Cancer Prev, 9, 449-52.
  23. Pakhomov S, Jacobsen SJ, Chute CG, Roger VL (2008). Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care 14, 530-9.
  24. Palmer B, Walsh G, Mckinna J, Greening W (1980). Adjuvant chemotherapy for breast cancer: side effects and quality of life. BMJ, 281, 1594-7. https://doi.org/10.1136/bmj.281.6255.1594
  25. Royer HR, Phelan CH, Heidrich SM (2009). Older breast cancer survivors' symptom beliefs. Oncol nurs forum, 36, 463-70. https://doi.org/10.1188/09.ONF.463-470
  26. Russo F, Linsalata M, Clemente C, et al (2013). The effects of fluorouracil, epirubicin, and cyclophosphamide (fec60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer, 13, 56. https://doi.org/10.1186/1471-2407-13-56
  27. Rustoen T (1995). Hope and quality of life, two central issues for cancer patients: a theoretical analysis. Cancer Nurs, 18, 355-61.
  28. Scott N, Fayers P, Aaronson N, et al (2008). EORTC-QLQ-C30 reference values (2008). European organization for research and treatment of cancer, Brussels, Belgium.
  29. Sharma R, Tobin P, Clarke SJ (2005). Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol, 6, 93-102. https://doi.org/10.1016/S1470-2045(05)01735-3
  30. Singer P, Martin D, Kelner M (1999). Quality end-of-life care: patients' perspectives. JAMA, 281, 163-8. https://doi.org/10.1001/jama.281.2.163
  31. Valderas JM, Kotzeva A, Espallargues M, et al (2008). The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res, 17, 179-93. https://doi.org/10.1007/s11136-007-9295-0
  32. Watters JM, Yau JC, O'rourke K, et al (2003). Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Ann Oncol, 14, 1744-1750. https://doi.org/10.1093/annonc/mdg497
  33. Wolf I, Sadetzki S, Catane R, et al (2005). Diabetes mellitus and breast cancer. Lancet Oncol, 6, 103-11. https://doi.org/10.1016/S1470-2045(05)01736-5
  34. Yusoff N, Low W, Yip C (2010). The malay version of the european organization forresearch and treatment of cancer quality of life questionnaire (eortc-qlq c30): reliability and validity study. Med J Malaysia, 9, 45-50.
  35. Yusuf A, Abdul Hadi U, Mahamood Z, et al (2013). Quality of life in malay and chinese women newly diagnosed with breast cancer in kelantan, malaysia. Asian Pac J Cancer Prev, 14, 435-40. https://doi.org/10.7314/APJCP.2013.14.1.435
  36. Zainal AO, Nor Saleha IT (2011). The national cancer registry report. 2007. Ministry of health, Malaysia.